EBOS Group Limited/Announcement
EBOS Group Limited logo

Coline McConville appointed as an independent director

Director Appointment22 December 2024EBOHealthcare

23 December 2024

NZX/ASX Code: EBO


Coline McConville appointed as an independent director


EBOS Group Limited (EBOS) is pleased to announce the appointment of Ms Coline McConville as an

independent director, effective 1 February 2025.


Ms McConville joins EBOS with over 20 years of governance experience across a wide range of

organisations operating in different countries and industries, primarily in the UK and Europe.


Ms McConville is currently a director of Kings Cross Central General Partnership and 3i Group plc and

a member of the Supervisory Board of German-based Tui AG. Her previous directorships include TUI

Travel, UTV Media, Travis Perkins, Fevertree Drinks, Inchcape, Wembley National Stadium, Shed

Media, Halifax and HBOS.


During her executive career, Ms McConville was Chief Executive Officer and Chief Operating Officer

of Clear Channel Communications (now iHeartMedia Inc.) and a management consultant with

McKinsey and LEK.


Ms McConville, is an Australian citizen currently residing in the UK. It is expected that she will be

returning to Australia in the near term. She holds a Bachelor of Laws and Bachelor of Jurisprudence

from the University of New South Wales and an MBA from Harvard Business School.


EBOS Chair Liz Coutts said “Coline brings a range of skills and governance experience to EBOS

including strategic thinking, acquisition and integration, financial acumen, remuneration and

succession planning. We look forward to welcoming her to the Board.”


The Board has determined that Ms McConville will be an independent director (as defined in the

NZX Listing Rules).


This appointment is consistent with EBOS’ Board succession planning. EBOS has appointed five new

directors since July 2021 with a diverse mix of skills. Following the commencement of Mr Matt

Muscio on 1 January 2025 and Ms McConville on 1 February 2025, the Board will comprise seven

directors, of which six will be independent.



For further information please contact:

Martin Krauskopf

Executive General Manager, Strategy and Mergers & Acquisitions

+61 3 9918 5555


Authorised for lodgement with NZX and ASX by Janelle Cain, General Counsel, EBOS Group

Limited.





About EBOS Group


EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified

Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical

products. It is also a leading Australasian animal care brand owner, product marketer and

distributor.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.